Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 267

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 267
---
 Notes into 88,385 preferred D-2 shares.

The following table presents changes
in the fair value of the 2020 Notes and 2021 Notes:

| Balance as of January 1, 2023                          |     | $ |  6,472 |   |
| Conversion of the 2021 Notes into preferred D-2 shares |     |   | (1,086 | ) |
| Changes in fair value                                  |     |   |  2,019 |   |
| Balance as of December 31, 2023                        |     | $ |  7,405 |   |
| Issuance of additional 2020 Notes                      |     |   |    450 |   |
| Changes in fair value                                  |     |   | (3,483 | ) |
| Balance as of December 31, 2024                        |     | $ |  4,372 |   |

| NOTE 7:- | WARRANT LIABILITY |

| a. | As of January 1, 2023, the Company has issued 167,365 warrants in connection with                                                  
 the issuance of its convertible notes which are exercisable into convertible preferred D-2 shares. The warrants are exercisable at 
 the earlier of: (i) March 1, 2025, (ii) immediately prior to the closing of an IPO, (iii) upon occurrence of a Deemed Liquidation  
 Event, or (iv) immediately prior to the occurrence of a Liquidation Event, as described in Company’s Article of Association        
 (the “AOA”).                                                                                                                       |

A Deemed Liquidation Event, as defined
in the AOA, includes change of control event in which shareholders of the Company, immediately prior to the event, hold less than 50%
of the voting power in the Company (or the surviving entity) after the event, as well as an event in which the Company sells substantially
all of its assets. In the occurrence of a Deemed Liquidation Event, all of the Company’s assets legally available for distribution among
the shareholders of the Company would be distributed in accordance with the preference described above. A Liquidation Event,
as defined in the AOA, includes any dissolution, winding-up or liquidation of the Company, and any foreclosure by creditors of the Company
on substantially all assets of, or equity interests in the Company, all whether voluntarily or involuntarily.

The exercise price of each warrant is
$15.20.

The number